Hypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient: a case report

Hypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient: a case report

Abstract Background Given the current climate of the pandemic, lung cancer patients are especially vulnerable to complications from severe acute respiratory syndrome coronavirus 2 infection. As a high-risk population group, these patients are strongly advised to receive coronavirus disease 2019 vacc...

Full description

Bibliographic Details
Main Authors: Shreya Tripathy, Nathaniel Alvarez, Shubham Jaiswal, Ryan Williams, Munaf Al-Khadimi, Sarah Hackman, William Phillips, Supreet Kaur, Sherri Cervantez, William Kelly, Josephine Taverna
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Journal of Medical Case Reports
Subjects:
COVID-19
COVID-19 vaccine
Lung cancer
Lymphadenopathy
Case report
Online Access:https://doi.org/10.1186/s13256-022-03660-9

Internet

https://doi.org/10.1186/s13256-022-03660-9

Similar Items